Table 1 Patients characteristics
From: Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
| Â | No. |
|---|---|
Patients | 65 |
Mean age(years) | 64(range, 41-76) |
Sex(male/female) | Â |
Male | 61 |
Female | 4 |
Smoking history | 21 |
Histological type | Â |
Well differentiated | 21 |
Moderately differentiated | 28 |
Poorly differentiated | 16 |